Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Accumulated Expenses (2018 - 2025)

TELA Bio (TELA) has 8 years of Accumulated Expenses data on record, last reported at $14.6 million in Q3 2025.

  • For Q3 2025, Accumulated Expenses rose 1.56% year-over-year to $14.6 million; the TTM value through Sep 2025 reached $14.6 million, up 1.56%, while the annual FY2024 figure was $7.3 million, 20.32% down from the prior year.
  • Accumulated Expenses reached $14.6 million in Q3 2025 per TELA's latest filing, up from $6.4 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $14.6 million in Q3 2025 and bottomed at $2.2 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $7.7 million, with a median of $6.4 million recorded in 2025.
  • Peak YoY movement for Accumulated Expenses: surged 194.67% in 2022, then tumbled 49.2% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $8.2 million in 2021, then skyrocketed by 33.18% to $10.9 million in 2022, then fell by 15.21% to $9.2 million in 2023, then decreased by 20.32% to $7.3 million in 2024, then skyrocketed by 98.88% to $14.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $14.6 million in Q3 2025, $6.4 million in Q2 2025, and $5.5 million in Q1 2025.